Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To compare the efficacy and safety of rho kinase inhibitors to placebo or other glaucoma medication in people diagnosed with open-angle glaucoma or ocular hypertension.

Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension / Clement Freiberg J.; von Spreckelsen A.; Khachatryan N.; Kolko M.; Azuara-Blanco A.; Virgili G.. - In: COCHRANE LIBRARY. - ISSN 1465-1858. - ELETTRONICO. - 2020:(2020), pp. CD013817.0-CD013817.0. [10.1002/14651858.CD013817]

Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension

Virgili G.
Writing – Review & Editing
2020

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To compare the efficacy and safety of rho kinase inhibitors to placebo or other glaucoma medication in people diagnosed with open-angle glaucoma or ocular hypertension.
2020
2020
0
0
Clement Freiberg J.; von Spreckelsen A.; Khachatryan N.; Kolko M.; Azuara-Blanco A.; Virgili G.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1347774
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 12
social impact